Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2022 Mar 29;12:5347. doi: 10.1038/s41598-022-09460-x

Publisher Correction: Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway

Athina Dritsoula 1,, Laura Dowsett 1, Camilla Pilotti 1, Marie N O’Connor 1, Stephen E Moss 1, John Greenwood 1
PMCID: PMC8964769  PMID: 35351967

Correction to: Scientific Reports 10.1038/s41598-022-08516-2, published online 22 March 2022

The original version of this Article contained an error in Figure 6 where the red circles around the question marks were incorrectly added in the published figure.

The original Figure 6 and accompanying legend appear below.

Figure 6.

Figure 6

IL-6-dependent induction of LRG1 and proposed downstream angiopathic effector mechanisms. IL-6 induces LRG1 in endothelial cells, but not mural cells. LRG1 may then act in an autocrine loop on endothelial cells through the TGFβ receptor complex to activate canonical and non-canonical signalling that will modify endothelial cell function and induce vascular destabilising genes. In turn, the LRG1-mediated induction of angiocrine factors may result in indirect angiopathic effects on endothelial cells and mural cells. Alternatively, LRG1 may signal in a paracrine fashion directly on mural cells to drive destabilisation. Dashed lines with question marks represent speculative pathways. Created with Biorender.com.

The original Article has been corrected.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES